The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling

We generated afatinib resistant clones of H1975 lung cancer cells by transient exposure of established tumors to the drug and collected the re-grown tumors. Afatinib resistant H1975 clones did not exhibit any additional mutations in proto-oncogenes when compared to control clones. Afatinib resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Booth, Laurence, Roberts, Jane L., Tavallai, Mehrad, Webb, Timothy, Leon, Daniel, Chen, Jesse, McGuire, William P., Poklepovic, Andrew, Dent, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991406/
https://www.ncbi.nlm.nih.gov/pubmed/26934000
http://dx.doi.org/10.18632/oncotarget.7746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991406/
https://www.ncbi.nlm.nih.gov/pubmed/26934000
http://dx.doi.org/10.18632/oncotarget.7746

Ejemplares similares